Literature DB >> 21344397

p8 expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis.

Maria Jose Sandi1, Tewfik Hamidi, Cédric Malicet, Carla Cano, Céline Loncle, Anne Pierres, Jean Charles Dagorn, Juan L Iovanna.   

Abstract

p8 is a stress gene whose activity is necessary for tumor development and progression. The acquisition of invasive properties by transformed cells is a key event in tumor development. In order to establish whether p8 is involved or not in this phenomenon, we assessed the capacity of p8 at influencing cell adhesion, migration, invasion, and tumorigenesis of pancreatic cancer cells. p8 expression was knocked down by a small interfering RNA (siRNA) in pancreatic cancer-derived Panc-1 and MiaPaCa-2 cells and subsequent changes in cell adhesion, migration, invasion, and tumorigenesis were assessed. Influence of p8 silencing on gene expression was analyzed using cDNA microarrays. The influence of inhibiting CDC42, one of the genes most over-expressed in p8-silenced cells, on the changes observed in p8-silenced cells was also evaluated. Finally, the tumorigenic capacities of Panc-1 cells transfected with control siRNA or p8 siRNA were compared by assessing their ability to form colonies in soft agar and to grow as xenografts in nude mice. Knocking-down p8 in pancreatic cancer cells in vitro decreased migration and invasion while increasing cell adhesion; over-expression produced the opposite effect. Knocking down CDC42 reversed almost completely the effects of silencing p8 in vitro. Finally, cells transfected with p8 siRNA were almost unable to form colonies in soft agar. In addition, p8-deficient Panc-1 cells did not develop tumors when injected subcutaneously in nude mice. In conclusion, p8 expression controls pancreatic cancer cell migration, invasion and adhesion, three processes required for metastasis, at least in part, through CDC42, a major regulator of cytoskeleton organization.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344397     DOI: 10.1002/jcp.22702

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis.

Authors:  Patricia Santofimia-Castaño; Yi Xia; Wenjun Lan; Zhengwei Zhou; Can Huang; Ling Peng; Philippe Soubeyran; Adrián Velázquez-Campoy; Olga Abián; Bruno Rizzuti; José L Neira; Juan Iovanna
Journal:  J Clin Invest       Date:  2019-03-28       Impact factor: 14.808

2.  NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells.

Authors:  Yanchao Mu; Xiaojie Yan; Ding Li; Dan Zhao; Lingling Wang; Xiaoyang Wang; Dan Gao; Jie Yang; Hua Zhang; Yanzhe Li; Yanan Sun; Yiliang Wei; Zhenfa Zhang; Xinzhong Chang; Zhi Yao; Shanshan Tian; Kai Zhang; Lance S Terada; Zhenyi Ma; Zhe Liu
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

3.  Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1.

Authors:  Maria Belen Lopez; Maria Noé Garcia; Daniel Grasso; Jennifer Bintz; Maria Inés Molejon; Gabriel Velez; Gwen Lomberk; Jose Luis Neira; Raul Urrutia; Juan Iovanna
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

4.  Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Authors:  Núria Pedrola; Laura Devis; Marta Llauradó; Irene Campoy; Elena Martinez-Garcia; Marta Garcia; Laura Muinelo-Romay; Lorena Alonso-Alconada; Miguel Abal; Francesc Alameda; Gemma Mancebo; Ramon Carreras; Josep Castellví; Sílvia Cabrera; Antonio Gil-Moreno; Xavier Matias-Guiu; Juan L Iovanna; Eva Colas; Jaume Reventós; Anna Ruiz
Journal:  Clin Exp Metastasis       Date:  2015-04-30       Impact factor: 5.150

5.  Oncogenic Role of NUPR1 in Ovarian Cancer.

Authors:  Jiangtao Yu; Haiyan Zhu; Rui Li; Qi Jiang; Wenqing Luan; Juanjuan Shi; Peishu Liu
Journal:  Onco Targets Ther       Date:  2020-11-30       Impact factor: 4.147

6.  Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.

Authors:  Marine Gilabert; Maria Inés Vaccaro; Martin E Fernandez-Zapico; Ezequiel L Calvo; Olivier Turrini; Véronique Secq; Stéphane Garcia; Vincent Moutardier; Gwen Lomberk; Nelson Dusetti; Raul Urrutia; Juan L Iovanna
Journal:  J Cell Physiol       Date:  2013-09       Impact factor: 6.384

7.  Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer.

Authors:  Carla E Cano; María José Sandí; Tewfik Hamidi; Ezequiel L Calvo; Olivier Turrini; Laurent Bartholin; Céline Loncle; Véronique Secq; Stéphane Garcia; Gwen Lomberk; Guido Kroemer; Raul Urrutia; Juan L Iovanna
Journal:  EMBO Mol Med       Date:  2012-07-23       Impact factor: 12.137

8.  Expression and roles of NUPR1 in cholangiocarcinoma cells.

Authors:  Ki-Sun Kim; Du-Il Jin; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2012-03-31

9.  Altering cancer transcriptomes using epigenomic inhibitors.

Authors:  Malaina Gaddis; Diana Gerrard; Seth Frietze; Peggy J Farnham
Journal:  Epigenetics Chromatin       Date:  2015-02-24       Impact factor: 4.954

10.  Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.

Authors:  Zhi-Qiang Wang; Mamadou Keita; Magdalena Bachvarova; Stephane Gobeil; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.